Web1 jun. 2007 · Methods for prediction of hepatic clearance (CLH) in man have been evaluated. A physiologically‐based in‐vitro to in‐vivo (PB‐IVIV) method with human unbound fraction in blood (fu,bl) and hepatocyte intrinsic clearance (CLint)‐data has a good rationale and appears to give the best predictions (maximum ∼2‐fold errors; < 25% errors for half … Web1 mrt. 2024 · CLint values of chemicals obtained with human hepatocytes as reported in the literature (A) and related calculated CLint,u values (B). Each dot represents a single CLint or CLint,u value and the dash represents the median for all CLint or CLint,u values of the chemical in the dataset.
Comparison of Intrinsic Clearance in Liver Microsomes …
Web1 apr. 2016 · A key requirement in drug discovery is to accurately define intrinsic clearance (CL int) values of less than 1 µ l/min/10 6 hepatocytes, which requires assays that allow for longer incubation time as a complement to suspended hepatocytes. This study … Web1 feb. 2012 · Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data. P. Poulin, S. Haddad; ... It is recommended that PB‐IVIV with human hepatocyte CLint and fu,bl is applied and improved, limits for acceptable errors are decreased, and that animal CLH‐studies and … default windows server product keys
Current Drug Metabolism - Bentham Science Publishers
Web• Hepatocytes contain the full complement of hepatic drug metabolising enzymes (both phase I and phase II) maintained within the intact cell. ‘Human hepatocytes have become the “gold standard” for evaluating hepatic metabolism and toxicity of drugs and other xenobiotics in vitro.’ Web1 okt. 2024 · Hepatic elimination is the net result of drug uptake over the sinusoidal membrane (carrier- and non–carrier-mediated), followed by metabolism and/or biliary … Web1 mei 2006 · With a broad complement of drug-metabolizing enzymes, hepatocytes catalysed measurable CLint values for a greater proportion of the reference compounds and were particularly proficient at defining metabolic rates for drugs with predominantly phase 2 metabolic routes. 47 View 1 excerpt fee committee lpc